{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:30:29Z","timestamp":1760149829940,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Alport syndrome is a hereditary disorder caused by pathogenic variants in the COL4A gene, which can be inherited in an autosomal recessive, dominant, or X-linked pattern. In the Bukharian Jewish population, no founder pathogenic variant has been reported in COL4A4. Methods: The cohort included 38 patients from 22 Bukharian Jewish families with suspected Alport syndrome who were referred the nephrogenetics clinic between 2012 and 2022. The study collected demographic, clinical, and genetic data from electronic medical records, which were used to evaluate the molecular basis of the disease using Sanger sequencing, and next-generation sequencing. Results: Molecular diagnosis was confirmed in 20\/38 patients, with each patient having at least one of the three disease-causing COL4A4 variants detected: c.338G&lt;A (p.Gly113Asp), c.3022G&gt;A (p.Gly1008Arg), and c.871-6T&gt;C. In addition, two patients were obligate carriers. Overall, there were 17 heterozygotes, 2 compound heterozygotes, and 3 homozygotes. Each variant was detected in more than one unrelated family. All patients had hematuria with\/without proteinuria at referral, and the youngest patient with proteinuria (age 5 years) was homozygous for the c.338G&gt;A variant. End-stage renal disease was diagnosed in two patients at the age of 38 years, a compound heterozygote for c.338G&gt;A and c.871-6T&gt;C. Hearing deterioration was detected in three patients, the youngest aged 40 years, all of whom were heterozygous for c.338G&gt;A. Conclusion: This study unveils three novel disease-causing variants, c.3022G&gt;A, c.871-6T&gt;C, and c.338G&gt;A, in the COL4A4 gene that are recurrent among Jews of Bukharian ancestry, and cause Alport syndrome in both dominant and recessive autosomal inheritance patterns.<\/jats:p>","DOI":"10.3390\/genes14101854","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:40:22Z","timestamp":1695552022000},"page":"1854","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential Founder Variants in COL4A4 Identified in Bukharian Jews Linked to Autosomal Dominant and Autosomal Recessive Alport Syndrome"],"prefix":"10.3390","volume":"14","author":[{"given":"Michal","family":"Levy","sequence":"first","affiliation":[{"name":"The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva 49100, Israel"},{"name":"School of Medicine, Tel Aviv University, Tel Aviv P.O.B 39040, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Bazak","sequence":"additional","affiliation":[{"name":"The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Lev-El","sequence":"additional","affiliation":[{"name":"The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotem","family":"Greenberg","sequence":"additional","affiliation":[{"name":"The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesia","family":"Kropach","sequence":"additional","affiliation":[{"name":"School of Medicine, Tel Aviv University, Tel Aviv P.O.B 39040, Israel"},{"name":"Pediatric Genetics Unit, Schneider Children\u2019s Medical Center, Petah Tikva 4920235, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Basel-Salmon","sequence":"additional","affiliation":[{"name":"The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva 49100, Israel"},{"name":"School of Medicine, Tel Aviv University, Tel Aviv P.O.B 39040, Israel"},{"name":"Felsenstein Medical Research Center, Petach Tikva 4920235, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idit","family":"Maya","sequence":"additional","affiliation":[{"name":"The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva 49100, Israel"},{"name":"School of Medicine, Tel Aviv University, Tel Aviv P.O.B 39040, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fped.2018.00011","article-title":"Basement Membrane Defects in Genetic Kidney Diseases","volume":"6","author":"Chew","year":"2018","journal-title":"Front. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ki.1994.413","article-title":"Immunohistochemical study of \u03b11-5 chains of type IV collagen in hereditary nephritis","volume":"46","author":"Nakanishi","year":"1994","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00005792-199909000-00005","article-title":"Alport Syndrome: An Inherited Disorder of Renal, Ocular, and Cochlear Basement Membranes","volume":"78","author":"Kashtan","year":"1999","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/cge.12919","article-title":"Alport syndrome: Impact of digenic inheritance in patients management","volume":"92","author":"Fallerini","year":"2017","journal-title":"Clin. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A \u201cEuropean Community Alport Syndrome Concerted Action\u201d Study","volume":"14","author":"Jais","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/ndt\/gfu254","article-title":"End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases","volume":"29","author":"Mallett","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","article-title":"Natural History and Genotype\u2013Phenotype Correlation in Female X-Linked Alport Syndrome","volume":"2","author":"Yamamura","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng0994-77","article-title":"Identification of mutations in the \u03b13(IV) and \u03b14(IV) collagen genes in autosomal recessive Alport syndrome","volume":"8","author":"Mochizuki","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"436046","DOI":"10.5402\/2012\/436046","article-title":"Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients","volume":"2012","author":"Gross","year":"2012","journal-title":"ISRN Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2019.12.015","article-title":"A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport\u2019s syndrome","volume":"97","author":"Gross","year":"2020","journal-title":"Kidney Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","article-title":"Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: A systematic review","volume":"13","author":"Matthaiou","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1093\/ndt\/gft253","article-title":"Molecular genetics of familial hematuric diseases","volume":"28","author":"Deltas","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2215\/CJN.01000116","article-title":"Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome","volume":"11","author":"Kamiyoshi","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","article-title":"Thin basement membrane nephropathy","volume":"64","author":"Savige","year":"2003","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mgg3.73","article-title":"Genetics and genomic medicine in Israel","volume":"2","author":"Zlotogora","year":"2014","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40246-017-0100-z","article-title":"The Israeli National Genetic database: A 10-year experience","volume":"11","author":"Zlotogora","year":"2017","journal-title":"Hum. Genom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s004390050429","article-title":"Common ancestry of three Ashkenazi-American families with Alport syndrome and COL4A5 R1677Q","volume":"99","author":"Barker","year":"1997","journal-title":"Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cge.12247","article-title":"A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population","volume":"86","author":"Webb","year":"2013","journal-title":"Clin. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jmoldx.2012.06.005","article-title":"Skin Biopsy Is a Practical Approach for the Clinical Diagnosis and Molecular Genetic Analysis of X-Linked Alport\u2019s Syndrome","volume":"14","author":"Wang","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: Natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"18097","DOI":"10.1038\/s41598-021-97414-0","article-title":"mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/humu.23364","article-title":"Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome","volume":"39","author":"Daga","year":"2017","journal-title":"Hum. Mutat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41467-017-00141-2","article-title":"Annotating pathogenic non-coding variants in genic regions","volume":"8","author":"Gelfman","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting Splicing from Primary Sequence with Deep Learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajhg.2020.09.011","article-title":"Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies","volume":"107","author":"Amendola","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00467-015-3302-4","article-title":"Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy","volume":"31","author":"Weber","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: A unified classification of genetic disorders of collagen IV \u03b1345: A position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for Genetic Testing and Management of Alport Syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","article-title":"Alport Syndrome: Achieving Early Diagnosis and Treatment","volume":"77","author":"Kashtan","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41598-022-06525-9","article-title":"Genotype\u2013phenotype correlations for COL4A3\u2013COL4A5 variants resulting in Gly substitutions in Alport syndrome","volume":"12","author":"Gibson","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"865034","DOI":"10.3389\/fmed.2022.865034","article-title":"Genotype-Phenotype Correlations for Pathogenic COL4A3\u2013COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome","volume":"9","author":"Savige","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.ajkd.2021.02.326","article-title":"Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study","volume":"78","author":"Furlano","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","article-title":"Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Gregg","year":"2021","journal-title":"Genet. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/10\/1854\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:56:53Z","timestamp":1760129813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/10\/1854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["genes14101854"],"URL":"https:\/\/doi.org\/10.3390\/genes14101854","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2023,9,23]]}}}